Furthermore, in our study, an imbalance of Treg/Th22 cells was found to induce abnormal microinflammation in uremic patients receiving HD, as supported by elevated levels of IL-22, CRP, TNF-α, IL-6, and a decreased IL-10 level among the PBMCs of patients treated with HD. Here, IL22 is linked to Huntington disease.